Communicable Disease Investigation Reference Manual
Table of Contents
1.0 Introduction
(Revised 8/13)
2.0 Map - Districts for Statewide Disease Investigation/Terrorism Response/TB Control
(Updated 7/19)
3.0 Communicable Disease Surveillance
(Updated 12/14)
4.0 Diseases or Conditions
(4/08)
(7/03)
(Revised 2/11)
Arboviral Diseases, Neuroinvasive and Non-Neuroinvasive
(Revised 4/15)
California Serogroup Viruses, including La Crosse Virus
Chikungunya Virus
Eastern Equine Encephalitis Virus
Powassan Virus
St. Louis Encephalitis Virus
Venezuelan Equine Encephalitis Virus
West Nile
Western Equine Encephalitis
(New 5/16)
(Revised 12/13)
(Revised 10/13)
(Revised 3/15)
Chancroid
Under construction
Chlamydia Trachomatis
Under construction
(Updated 4/12)
(Revised 1/12)
(Revised 5/16)
(Revised 8/11)
(Revised 10/11)
(Revised 1/15)
(Updated 3/12)
Escherichia coli O157:H7/Other Hemorrhagic E. coli
(Revised 6/11)
(Revised 4/08)
(Revised 2/14)
(Updated 3/12)
Gonorrhea
Under construction
Haemophilus influenzae, Invasive
(Revised 1/15)
(Revised 4/12)
(Revised 6/15)
Hemolytic Uremic Syndrome (HUS), post-diarrheal
(Revised 6/11)
(Updated 11/15)
Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)
Arenaviridae: Lassa Fever (Old World Arenavirus)
Bunyaviridae: Crimean-Congo Hemorrhagic Fever
Filoviridae: Ebola Hemorrhagic Fever
Filoviridae: Marburg Hemorrhagic Fever
(Revised 4/19)
Hepatitis B
(Revised 4/19)
(Revised 6/08)
HIV/AIDS
Under construction
(Updated 6/17)
(Revised 3/14)
(Revised 12/13)
(Updated 11/15)
(Updated 1/14)
(Revised 5/08)
(Revised 3/14)
(Updated 8/13)
(Updated 10/19)
Methicillin–resistant Staphylococcus aureus (MRSA)
(5/11)
(Revised 8/13)
Nontuberculous Mycobacterium (NTM) / MOTT
(Revised 1/15)
(Revised 7/14)
Other Sexually Transmitted Diseases
Under construction
Nongonococcal Urethritis
Mucopurulent Cervicitis
Bacterial Vaginosis
Trichomonal Vaginosis
Vulvovaginal Candidiasis
Genital Herpes
Lymphogranuloma Venereum
Molluscum Contagiousum
Pelvic Inflammatory Disease (PID)
Urinary Tract Infection
Human Papillomavirus
Acute Epididymitis
(2/11)
Perinatal Hepatitis B Case Management Form - PHB 29
(Revised 3/14)
(Revised 9/12)
(Updated 5/12)
(Revised 1/16)
(Revised 5/15)
Rabies
(Revised 1/14)
(Revised 1/14)
(Updated 2/13)
Rocky Mountain Spotted Fever/Spotted Fever Rickettsioses
(Revised 2/20)
(Revised 11/13)
Salmonellosis, Nontyphoidal (NTS)
(Revised 6/17)
Shiga toxin-producing E. coli (STEC) and
Shiga toxin positive, unknown organism
(Revised 6/11)
(Revised 6/17)
(Revised 11/13)
Streptococcus pneumoniae, Invasive Pneumococcal Disease (IPD)
(New 6/17)
Streptococcal Toxic Shock Syndrome
(Revised 2/16)
Syphilis
Under construction
Revised (5/16)
(Revised 11/13)
Toxic Shock Syndrome, Non-Streptococcal
(Revised 5/16)
(Revised 4/15)
(Revised 3/12)
(Revised 4/16)
(Revised 7/15)
(Revised 4/05)
(5/11)
(Revised 5/11)
Vibriosis (non-cholera Vibrio species infections)
(11/12)
(Updated 10/15)
(Revised 3/12)
(Revised 9/10)
Key
New
Recently added manual section.
Reviewed
Section content is current.
Revised
Section content: may include reporting guidelines, forms, and intervention recommendations.
Updated
Web links, agency names and phone numbers.